Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments - Wikidata - wikimedia - TriplyDB

Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments

Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments

http://www.wikidata.org/entity/Q34194782

about

Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases Cell migration in paediatric glioma; characterisation and potential therapeutic targeting.Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models.Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3 Functions of GSK-3 Signaling in Development of the Nervous System.Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma.Standardized orthotopic xenografts in zebrafish reveal glioma cell-line-specific characteristics and tumor cell heterogeneity.Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1.Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results.BKM-120 (Buparlisib): A Phosphatidyl-Inositol-3 Kinase Inhibitor with Anti-Invasive Properties in Glioblastoma.Natural compounds for pediatric cancer treatment.Systemic AAV9-IFNβ gene delivery treats highly invasive glioblastoma.Changes in tumor cell heterogeneity after chemotherapy treatment in a xenograft model of glioblastoma.Molecular dynamics study of the inhibitory effects of ChEMBL474807 on the enzymes GSK-3β and CDK-2.High-content analysis of tumour cell invasion in three-dimensional spheroid assays.PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT.Astrocytes promote glioma invasion via the gap junction protein connexin43.Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations

P2860

Q26739711-1B3724BD-6494-4395-A642-26E1D446F10E Q26784341-B1731E7D-C681-4EA4-8B35-83544CFCD19A Q27332147-40440783-1E55-4D33-B9C4-315DE6B7913E Q33869702-F2E0E0D8-9E19-4075-8F53-BC7FEA1772D8 Q35542572-BB0B4292-779C-494A-8D40-77F0A5A0A966 Q35564819-98E229FD-A89C-45CE-9765-08790FF2578A Q36082516-3AF787DB-9348-452E-AB63-DBE486744E7E Q36139783-C4888493-3960-483C-846B-5DE71E31BA20 Q36627739-94CF809E-DB02-4806-ABDF-B47A48E11D5E Q37108803-6A5E7375-E535-4E98-904C-6732711DCDD3 Q37592190-91D7A082-D420-4BFC-8344-A4526F191785 Q38016227-0A754334-010B-4EF1-AB84-42CFCF9D20FE Q38266139-9F0D78F8-1897-47BD-AEF3-0DD6F6E1A6B4 Q38663897-0ED9EFD3-1A96-4EE1-BE98-2EA4A96977FA Q38770085-D7F35C97-DC96-4688-ABAB-4CCF1A3F700A Q38773846-F058F494-217D-4967-BED5-DD6D0B8A1AE9 Q41261391-73941D6D-8039-49E4-BE85-66F9CA87E461 Q42353637-A5516217-80C7-432E-8912-705A729BC912 Q47109987-DBC66187-B525-416F-B037-E89CF2F74E51 Q52152185-8F5BFCA5-CB0B-474E-90E0-92580A9C6505 Q58764066-E067BA3E-8FF7-485F-9688-F9F9AF2C1CBB

P2860

Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments

http://www.wikidata.org/entity/Q34194782

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Indirubins decrease glioma inv ...... endothelial cell compartments

@ast

Indirubins decrease glioma inv ...... endothelial cell compartments

@en

Indirubins decrease glioma inv ...... endothelial cell compartments

@nl

type

label

Indirubins decrease glioma inv ...... endothelial cell compartments

@ast

Indirubins decrease glioma inv ...... endothelial cell compartments

@en

Indirubins decrease glioma inv ...... endothelial cell compartments

@nl

prefLabel

Indirubins decrease glioma inv ...... endothelial cell compartments

@ast

Indirubins decrease glioma inv ...... endothelial cell compartments

@en

Indirubins decrease glioma inv ...... endothelial cell compartments

@nl

P1433

Q34194782-088D7A8D-F7EA-4915-9700-00A3D01B2AB2

P1476

Q34194782-347977CC-F8EA-46FB-8443-1692A31D1D82

P2093

Q34194782-0ABB0A0F-16C2-4643-A746-116C994E128B

Q34194782-1309AB31-1009-4A3E-9B41-5E7D078098D3

Q34194782-1997C246-35EF-48D7-8B75-968FD74550C6

Q34194782-5D0EB59D-099B-452C-85FC-4DE002B33123

Q34194782-80FBA692-510D-4890-A412-1A62160E6FA3

Q34194782-8673B3C0-1567-499E-AD19-2388CD3A9286

Q34194782-AE76B8FB-FAEB-4564-8878-FFB3B7D775E3

Q34194782-B7FEC5D3-2481-4629-8A0D-6B24F139A1B6

Q34194782-C53BDEF9-A550-4E8D-822E-FA98B08CD6C7

P2860

Q34194782-03F0036D-104B-4FC6-91EB-B07F4A24AA39

Q34194782-07A53D3D-F2F9-481E-9235-6A5CB3B6F6EB

Q34194782-14D5AA79-B1D7-4A7C-A744-A33D323465FB

Q34194782-23381EB6-E432-47DB-B334-6CF86EE4502B

Q34194782-2C877F19-D8A2-445B-9F7A-9CCA799EBF71

Q34194782-2EF22E1D-5CE5-4C05-9DF5-F26503C08251

Q34194782-32D3C0D3-3A25-4E67-90DC-1872E3F69D75

Q34194782-3F486FEC-6FE0-41A3-848D-CAABFAA591B7

Q34194782-558345CF-0B47-4ECF-A4A9-4F22D0E217B5

Q34194782-604A49E2-0284-4520-8990-DA7B644EC1C5

P304

Q34194782-409CA1EC-5075-4841-B945-4F767B94F624

P31

Q34194782-8E967D19-0681-46C4-BA17-77F5BDD61A15

P356

Q34194782-7E7A0F34-86A5-4229-91BB-55CE615CEC08

P407

Q34194782-7B84BB83-7672-4C2E-873C-E9653D9B092F

P433

Q34194782-32154187-AE67-420F-9F81-618CD240BB7E

P478

Q34194782-5D6B7CFC-6EFB-425A-81CC-FD81AE31511C

P50

Q34194782-CF379785-3A26-496B-936B-2B454EA07CDF

P577

Q34194782-3A71C237-7AA4-45A8-8F1D-2688F58860AC

P698

Q34194782-21D20035-43EF-47FE-AA0B-282EF9091E74

P921

Q34194782-CACB7939-7B0A-457F-83A8-EDF24B4A1BC6

P932

Q34194782-8693947B-F52A-4F20-BEA8-258B768392FB

P356

0008-5472.CAN-10-3026

P1433

Cancer Research

P1476

Indirubins decrease glioma inv ...... endothelial cell compartments

@en

P2093

Balveen Kaur

http://www.w3.org/2001/XMLSchema#string

E Antonio Chiocca

http://www.w3.org/2001/XMLSchema#string

Fang Liu

http://www.w3.org/2001/XMLSchema#string

Jakub Godlewski

http://www.w3.org/2001/XMLSchema#string

Michal O Nowicki

http://www.w3.org/2001/XMLSchema#string

Rachael Press

http://www.w3.org/2001/XMLSchema#string

Sean E Lawler

http://www.w3.org/2001/XMLSchema#string

Shanté P Williams

http://www.w3.org/2001/XMLSchema#string

Soledad A Fernandez

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion

GSK-3: tricks of the trade for a multi-tasking kinase

Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation

GSK-3-selective inhibitors derived from Tyrian purple indirubins

Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity

Malignant astrocytic glioma: genetics, biology, and paths to treatment

A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling

Cost of migration: invasion of malignant gliomas and implications for treatment.

Pharmacological inhibitors of glycogen synthase kinase 3.

P304

5374-5380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-3026

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

Mahmoud Abdel-Rasoul

P577

2011-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21697283

http://www.w3.org/2001/XMLSchema#string

P921

P932

4288480

http://www.w3.org/2001/XMLSchema#string